Achieve Life Sciences offers a compelling risk/reward profile with its promising smoking cessation therapy, cytisinicline.

The Food and Drug Administration has given Aurobindo the green light for varenicline tablets, 0.5 mg and 1 mg. Aurobindo ...

For people trying to quit smoking, use of a GLP-1 receptor agonist may help prevent weight gain, a common barrier to quitting, researchers said here. In a systematic review and meta-analysis of three ...

Varenicline was approved for smoking-cessation treatment on May 11, 2006, under the trade name Chantix (Pfizer). A cost comparison of currently available smoking-cessation therapies appears in ...

Asthma–chronic obstructive pulmonary disease (COPD) overlap syndrome (ACOS) is a commonly encountered yet loosely defined clinical entity. ACOS accounts for approximately 15–25% of the ...

(NASDAQ:ACHV) reported its first quarter 2025 results, highlighting progress on the ORCA-OL study, preparation of the New Drug Application (NDA) for cytisinicline, and efforts on further ...

Lots of people who vape want to quit, but there’s very little guidance on how best to do so. In the U.S., recent reports estimate that 5.9% of youth and ...